Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Oxy'Pharm's eco-responsible automated surface disinfection systems are widely used globally across healthcare and related sectors. Their Nocospray device uses hydrogen peroxide vapor to achieve high-level decontamination of rooms up to thousands of cubic meters. The company’s products are certified as medical devices and comply with major European standards; they have demonstrated efficacy against a broad spectrum of pathogens including human coronaviruses. The company experienced significant growth during the COVID‑19 pandemic due to increased demand for effective surface decontamination solutions. No clinical trial results apply as these are not therapeutics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Oxy'Pharm.